“…A number of COVID‐19 vaccine preparations are now available, with administration currently recommended for all persons with diabetes. 12 Although some evidence suggests greater likelihood of thrombotic and coronary events among persons having COVID with the Janssen and Oxford‐AstraZeneca vaccines, the mRNA vaccines were associated with reduction in such events, 13 and a study from Hong Kong comparing 3218 unvaccinated persons with 5248 who had been vaccinated showed reduction in post‐COVID MI or stroke among persons with underlying CVD, with what appeared to be progressively greater reduction in such events with increasing number of doses either of an mRNA vaccine or a whole inactivated virus vaccine. 14 There are population studies suggesting potential adverse events.…”